Terms: = Bone cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
35 results:
1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract] [Full Text] [Related]
2. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP; Cagdas D; Castelle M; Chan AY; Chandrakasan S; Chetty K; Cougoul P; Crickx E; Dara J; Deyà-Martínez A; Farmand S; Formankova R; Gennery AR; Gonzalez-Granado LI; Hagin D; Hanitsch LG; Hanzlikovà J; Hauck F; Ivorra-Cortés J; Kisand K; Kiykim A; Körholz J; Leahy TR; van Montfrans J; Nademi Z; Nelken B; Parikh S; Plado S; Ramakers J; Redlich A; Rieux-Laucat F; Rivière JG; Rodina Y; Júnior PR; Salou S; Schuetz C; Shcherbina A; Slatter MA; Touzot F; Unal E; Lankester AC; Burns S; Seppänen MRJ; Neth O; Albert MH; Ehl S; Neven B; Speckmann C
J Allergy Clin Immunol; 2024 Jan; 153(1):275-286.e18. PubMed ID: 37935260
[TBL] [Abstract] [Full Text] [Related]
3. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract] [Full Text] [Related]
4. Effects of Ruxolitinib on Myeloproliferative Neoplasms via the Negative Regulators.
Wang SY; Xie XL; Liang JY; Cheng ZY
Clin Lab; 2023 Feb; 69(2):. PubMed ID: 36787550
[TBL] [Abstract] [Full Text] [Related]
5. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
[TBL] [Abstract] [Full Text] [Related]
6. Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients.
Zhao J; Zhao Y; Ma X; Feng H; Jia L
Sci Rep; 2022 Mar; 12(1):5029. PubMed ID: 35322804
[TBL] [Abstract] [Full Text] [Related]
7. New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity.
Barbanente A; Iacobazzi RM; Azzariti A; Hoeschele JD; Denora N; Papadia P; Pacifico C; Natile G; Margiotta N
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200051
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function.
Roberts LB; Jowett GM; Read E; Zabinski T; Berkachy R; Selkirk ME; Jackson I; Niazi U; Anandagoda N; Araki M; Araki K; Kasturiarachchi J; James C; Enver T; Nimmo R; Reis R; Howard JK; Neves JF; Lord GM
J Immunol; 2021 Jun; 206(11):2725-2739. PubMed ID: 34021046
[TBL] [Abstract] [Full Text] [Related]
9. bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets socs1 to facilitate progression of esophageal cancer.
Deng Y; Julaiti A; Ran W; He Y
Life Sci; 2021 Aug; 278():119491. PubMed ID: 33862112
[TBL] [Abstract] [Full Text] [Related]
10. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of socs1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
11. Characterization of DLBCL with a PMBL gene expression signature.
Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
[TBL] [Abstract] [Full Text] [Related]
12. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through socs1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.
Krześniak M; Zajkowicz A; Gdowicz-Kłosok A; Głowala-Kosińska M; Łasut-Szyszka B; Rusin M
Cell Signal; 2020 May; 69():109552. PubMed ID: 32032660
[TBL] [Abstract] [Full Text] [Related]
14. Epicatechin and scopoletin-rich Morinda citrifolia leaf ameliorated leukemia via anti-inflammatory, anti-angiogenesis, and apoptosis pathways in vitro and in vivo.
Ahmadi N; Mohamed S; Sulaiman Rahman H; Rosli R
J Food Biochem; 2019 Jul; 43(7):e12868. PubMed ID: 31353737
[TBL] [Abstract] [Full Text] [Related]
15. Surgical site infection in spinal metastasis: incidence and risk factors.
Sebaaly A; Shedid D; Boubez G; Zairi F; Kanhonou M; Yuh SJ; Wang Z
Spine J; 2018 Aug; 18(8):1382-1387. PubMed ID: 29355789
[TBL] [Abstract] [Full Text] [Related]
16. Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.
Hou HA; Lu JW; Lin TY; Tsai CH; Chou WC; Lin CC; Kuo YY; Liu CY; Tseng MH; Chiang YC; Peng YL; Tang JL; Gong Z; Lin LI; Tien HF
Blood Cancer J; 2017 Jul; 7(7):e588. PubMed ID: 28753595
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract] [Full Text] [Related]
18. Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin.
Lelli M; Roveri N; Marzano C; Hoeschele JD; Curci A; Margiotta N; Gandin V; Natile G
Dalton Trans; 2016 Aug; 45(33):13187-95. PubMed ID: 27397134
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of Circulating Tumor Cells in Prostate cancer Patients at PSA Recurrence and Review of the Literature.
Grisanti S; Antonelli A; Buglione M; Almici C; Foroni C; Sodano M; Triggiani L; Greco D; Palumbo C; Marini M; Magrini SM; Berruti A; Simeone C
Anticancer Res; 2016 Jun; 36(6):2975-81. PubMed ID: 27272813
[TBL] [Abstract] [Full Text] [Related]
20. Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.
David M; Naudin C; Letourneur M; Polrot M; Renoir JM; Lazar V; Dessen P; Roche S; Bertoglio J; Pierre J
Mol Oncol; 2014 Jul; 8(5):942-55. PubMed ID: 24726456
[TBL] [Abstract] [Full Text] [Related]
[Next]
